Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
scientific article
Author/s
author: Andrea Sartore-Bianchi, Alberto Bardelli, Salvatore Siena, Diether Lambrechts, Frédérique Penault-Llorca, Sabine Tejpar, Jef De Schutter, Eric Van Cutsem, Pierre Laurent-Puig, Hubert Piessevaux, Miriam Martini, Camilla Qvortrup, Federico Cappuzzo, Per Pfeiffer, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Fortunato Ciardiello, Josep Tabernero Caturla, George Fountzilas, David Bernasconi
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.